Patents by Inventor Daniel O'Keeffe
Daniel O'Keeffe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11471324Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: December 16, 2021Date of Patent: October 18, 2022Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi
-
Publication number: 20220280339Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: May 27, 2022Publication date: September 8, 2022Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Publication number: 20220280340Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: May 27, 2022Publication date: September 8, 2022Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Patent number: 11389327Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: December 16, 2021Date of Patent: July 19, 2022Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi
-
Publication number: 20220197435Abstract: Technology directed to low-emissions touch controller in in-cell touch display systems is described. One in-cell touch controller includes a signal generator circuit that is configured to generate a sense signal according to a sensing function, the sense signal including a windowed sinusoidal waveform. The controller generates a transition signal to transition the in-cell touch display between a display function and the sensing function. The controller drives the sense signal and the transition signal on common voltage (VCOM) layer of electrodes during a touch scanning interval. During a display function interval an integrated display driver is configured to drive a first signal on the VCOM layer of electrodes during a display function interval.Type: ApplicationFiled: January 14, 2022Publication date: June 23, 2022Applicant: Cypress Semiconductor CorporationInventors: Viktor Kremin, Oleksandr Pirogov, Jens Weber, Yarsolav Lek, Daniel O'Keeffe, Brendan Lawton, Khosrov D. Sadeghipour, Gaurav Panchanan, Andrew Kinane
-
Publication number: 20220168136Abstract: Controllers for dry eye treatment apparatus and methods are described herein which generally comprise a patch or strip affixed to the skin of the upper and/or lower eyelids to deliver heat to the one or more meibomian glands contained within the underlying skin. The treatment strip or strips include one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally without restriction from the one or more patches. A controller is in communication with the one or more strips and is programmable to monitor a temperature of the one or more strips to provide a treatment therapy above a threshold temperature. Additionally forceps for mechanically expressing the Meibomian glands may be included with the strips and/or controller.Type: ApplicationFiled: February 16, 2022Publication date: June 2, 2022Applicant: Sight Sciences, Inc.Inventors: Paul BADAWI, David BADAWI, Scott HARSHMAN, Daniel O'KEEFFE
-
Patent number: 11344447Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: April 23, 2021Date of Patent: May 31, 2022Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi
-
Publication number: 20220104967Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: December 16, 2021Publication date: April 7, 2022Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Publication number: 20220104968Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: December 16, 2021Publication date: April 7, 2022Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Patent number: 11285040Abstract: Controllers for dry eye treatment apparatus and methods are described herein which generally comprise a patch or strip affixed to the skin of the upper and/or lower eyelids to deliver heat to the one or more meibomian glands contained within the underlying skin. The treatment strip or strips include one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally without restriction from the one or more patches. A controller is in communication with the one or more strips and is programmable to monitor a temperature of the one or more strips to provide a treatment therapy above a threshold temperature. Additionally forceps for mechanically expressing the Meibomian glands may be included with the strips and/or controller.Type: GrantFiled: December 9, 2016Date of Patent: March 29, 2022Assignee: Sight Sciences, Inc.Inventors: Paul Badawi, David Badawi, Scott Harshman, Daniel O'Keeffe
-
Patent number: 11226706Abstract: Technology directed to low-emissions touch controller in in-cell touch display systems is described. One in-cell touch controller includes a signal generator circuit that is configured to generate a sense signal according to a sensing function, the sense signal including a windowed sinusoidal waveform. The controller generates a transition signal to transition the in-cell touch display between a display function and the sensing function. The controller drives the sense signal and the transition signal on common voltage (VCOM) layer of electrodes during a touch scanning interval. During a display function interval an integrated display driver is configured to drive a first signal on the VCOM layer of electrodes during a display function interval.Type: GrantFiled: September 18, 2020Date of Patent: January 18, 2022Assignee: Cypress Semiconductor CorporationInventors: Viktor Kremin, Oleksandr Pirogov, Jens Weber, Yarsolav Lek, Daniel O'Keeffe, Brendan Lawton, Khosrov D Sadeghipour, Gaurav Panchanan, Andrew Kinane
-
Publication number: 20210386584Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device, tool, or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Some systems described here may be configured to cut or tear the trabecular meshwork with the body of an elongate member located within Schlemm's canal. Other tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: August 9, 2021Publication date: December 16, 2021Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Patent number: 11116660Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: April 23, 2021Date of Patent: September 14, 2021Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi
-
Patent number: 11090188Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device, tool, or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Some systems described here may be configured to cut or tear the trabecular meshwork with the body of an elongate member located within Schlemm's canal. Other tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: April 29, 2019Date of Patent: August 17, 2021Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi
-
Publication number: 20210236332Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: April 23, 2021Publication date: August 5, 2021Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Publication number: 20210236333Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: ApplicationFiled: April 23, 2021Publication date: August 5, 2021Inventors: David Y. BADAWI, Daniel O'KEEFFE, Paul BADAWI
-
Publication number: 20210216168Abstract: Technology directed to low-emissions touch controller in in-cell touch display systems is described. One in-cell touch controller includes a signal generator circuit that is configured to generate a sense signal according to a sensing function, the sense signal including a windowed sinusoidal waveform. The controller generates a transition signal to transition the in-cell touch display between a display function and the sensing function. The controller drives the sense signal and the transition signal on common voltage (VCOM) layer of electrodes during a touch scanning interval. During a display function interval an integrated display driver is configured to drive a first signal on the VCOM layer of electrodes during a display function interval.Type: ApplicationFiled: September 18, 2020Publication date: July 15, 2021Applicant: Cypress Semiconductor CorporationInventors: Viktor Kremin, Oleksandr Pirogov, Jens Weber, Yarsolav Lek, Daniel O'Keeffe, Brendan Lawton, Khosrov D. Sadeghipour, Gaurav Panchanan, Andrew Kinane
-
Publication number: 20210177648Abstract: Controllers for dry eye treatment apparatus and methods are described herein which generally comprise a patch or strip affixed to the skin of the upper and/or lower eyelids to deliver heat to the one or more meibomian glands contained within the underlying skin. The treatment strip or strips include one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally without restriction from the one or more patches. A controller is in communication with the one or more strips and is programmable to monitor a temperature of the one or more strips to provide a treatment therapy above a threshold temperature of, e.g., 39° C., and below a maximum temperature of, e.g., 48° C., over a treatment period of 12 minutes.Type: ApplicationFiled: February 5, 2021Publication date: June 17, 2021Applicant: Sight Sciences, Inc.Inventors: David BADAWI, Paul BADAWI, Scott HARSHMAN, Daniel O'KEEFFE
-
Patent number: 10973680Abstract: Controllers for dry eye treatment apparatus and methods are described herein which generally comprise a patch or strip affixed to the skin of the upper and/or lower eyelids to deliver heat to the one or more meibomian glands contained within the underlying skin. The treatment strip or strips include one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally without restriction from the one or more patches. A controller is in communication with the one or more strips and is programmable to monitor a temperature of the one or more strips to provide a treatment therapy above a threshold temperature of, e.g., 39° C., and below a maximum temperature of, e.g., 48° C., over a treatment period of 12 minutes.Type: GrantFiled: December 11, 2015Date of Patent: April 13, 2021Assignee: Sight Sciences, Inc.Inventors: David Badawi, Paul Badawi, Scott Harshman, Daniel O'Keeffe
-
Patent number: 10888453Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.Type: GrantFiled: December 26, 2017Date of Patent: January 12, 2021Assignee: SIGHT SCIENCES, INC.Inventors: David Y. Badawi, Daniel O'Keeffe, Paul Badawi